« Previous Entries

Extremely High HDL Cholesterol Levels Can Be Harmful

Monday, August 28th, 2017

The age-old wisdom of too much of everything is bad applies to high-density lipoprotein (HDL) too, also known as good cholesterol. According to new research, when HDL is present in extremely high proportion, it does more harm than good. Cholesterol, as you would know, are two types: HDL and LDL cholesterol. It is widely believed […]

Handful of Almonds a Day Might Help Lower Your Risk of Heart Disease

Saturday, August 19th, 2017

Eating almonds regularly is good for your heart in two ways, according to a new study. The researchers noted that an almond inclusive diet improves HDL cholesterol and its function. HDL cholesterol, also known as the good cholesterol, helps increase HDL levels.  However, that’s not at all. Almonds also boost the function of the good […]

Lack of Sleep Might Lower good cholesterol count

Monday, April 25th, 2016

Earlier studies had hinted at a possible link between lack of sleep and increased risk of cardiovascular disease. A recent study offers a possible explanation for this. According to it, lack of sleep negatively affects cholesterol levels. The authors of the new study found that sleep deprivation triggered changes in those genes which play a […]

Amgen’s Repatha approved for high LDL cholesterol treatment

Tuesday, September 1st, 2015

The US Food and Drug Administration (FDA) has approved a new medication that can treatment high LDL cholesterol. The approved drug is evolocumab (brand name Repatha) from pharmaceutical firm Amgen. Repatha is the second drug in a new class of drugs to treat cholesterol medication called an injectable PCSK9 inhibitor. The drug has been approved […]

FDA approves alirocumab to treat high cholesterol

Saturday, July 25th, 2015

The US Food and Drug Administration (FDA) has approved a drug called alirocumab (brand name Praluent) from Sanofi-Aventis to treat high levels of cholesterol. This is the first injectable cholesterol medication in its class. John Jenkins, director of the Office of New Drugs at the Center for Drug Evaluation and Research, FDA, said, “Praluent provides […]

Untreated high cholesterol a problem among US Hispanics

Saturday, June 13th, 2015

A new study has found that just half of US Hispanics with high cholesterol knew about their condition, which poses a greater risk for the people. Among those Hispanic Americans who knew of their condition, just 30 percent received treatment. The study was led by Carlos Rodriguez of Wake Forest School of Medicine in Winston […]

Sanofi Praluent under FDA consideration for cholesterol treatment

Monday, June 1st, 2015

A novel cholesterol medication called alirocumab (brand name Praluent) by pharmaceutical company Sanofi is currently under FDA consideration. If approved, the new medication can offer another treatment option for patients suffering from high cholesterol. According to officials, treatment with this new medication may lower cholesterol levels farther than currently approved medications. The Associated Press has […]

One third of children face high cholesterol levels

Sunday, March 30th, 2014

High cholesterol levels in almost one third of 9-11 year old children may increase the risk of heart problems later in their lives, according to a new study. The study found that one in three kids have elevated total cholesterol levels, which may lead to heart issues later in life. The study was led by […]

Testing Strategies for Families of FH Patients under Question

Saturday, April 13th, 2013

A recent study shows that current testing strategies for family members of patients diagnosed with familial hypercholesterolemia may not be very efficient. The researchers of the study reported that 50 percent of FH patients had at least one mutation out of the three genes known to be associated with the condition. The remaining half, however, […]

Friedewald Equation Not Accurate for LDL Cholesterol Estimation

Friday, April 12th, 2013

A large-scale analysis confirms the results of smaller studies that suggested that the Friedewald Equation does not accurately estimate the level of LDL cholesterol, also known as ‘bad’ cholesterol and a significant contributor of heart and cardiovascular conditions. The study shows that the largest inaccuracies seemed to happen when LDL cholesterol concentration was relatively low […]

« Previous Entries